Skip to content

Understanding of individuals with Parkinson´s Disease about social isolation and ways of prevention, monitor, and Treatment Remotely to face the COVID-19 pandemic.

Perception of individuals with Parkinson´s Disease about social isolation and strategies of prevention, monitoring, and treatment through Telehealth to face the COVID-19 pandemic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7qwsyny
Enrollment
Unknown
Registered
2022-04-11
Start date
2020-09-21
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson disease

Interventions

This study has one experimental group composed by 40 individuals submitted to a physical therapy intervention online protocol for prevention, rehabilitation and health promotion. It consists on: Socia

Sponsors

Universidade Estadual de Londrina
Lead Sponsor
Universidade Estadual de Londrina
Collaborator

Eligibility

Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of idiopathic Parkinson´s disease confirmed by a movement disorders specialist in accordance with Parkinson’s Disease Society Brain Bank diagnostic criteria; both genders; age over 50 years; disease staging between 1.5 and 3 according to the modified Hoehn and Yahr scale; undergoing regular and stable pharmacological treatment; Mini-Mental State Examination score major ou equal to 24; no other associated neurological, musculoskeletal and/or cardiorespiratory diseases and the ability to walk independently; having a smartphone or computer and access to internet; knowledge about or available assistance on how to make video calls; and the ability to participate and provide written informed consent

Exclusion criteria

Exclusion criteria: Diagnosis of atypical Parkinson´s disease; neuropsychiatric comorbidities; inability to walk 10 meters; presence of severe dyskinesia that prevents the participant from sitting in a chair; not understanding any of the training protocol stages and experiencing severe pain and/or discomfort that precludes performing the proposed activities

Design outcomes

Primary

MeasureTime frame
It is aimed to quantify the improvement of functional lower extremity strength and identify movement strategies used to complete transitional movements through the Five Times Sit-to-Stand (5TSTS) Test, measuring the time (seconds). It is expected to reach values lower than 0.16 seconds in the post-intervention assessment, since values higher than this cut-off point indicate risk of falls

Secondary

MeasureTime frame
It is aimed to verify the reduction of fear of falling assessed by Falls Efficacy Scale (FES-I), with reduction in total score ponctuation of at least 6.8% on pre- and post-intervention measurements;An improvement in the quality of life assessed by the Parkinson´s Disease Questionnaire (PDQ-39) is expected, with a reduction in the total score punctuation by at least 6 points in the total score of the scale after the post-intervention measurement, which can be considered a minimum meaningful change;It is aimed to minimize the symptoms of depression and anxiety assessed by the Hospital Anxiety Depression Scale (HADS). The minimally important change for HADS-A is 1.84 and for HADS-D is 1.72 ;It is aimed to improve the signals and symptoms of Parkinson´s disease related to activities of daily life (ADL) assessed by Movement Disorders Society (MDS) – Unified Parkinson´s Disease Rating Scale part two (MDS-UPDRS II) with total score reduction reflecting at least 8.2%, the minimum detectable change, on pre- and post-intervention measurements;It is aimed to improve the cognition assessed by Verbal Fluency (VF) Test increasing the quantity of words informed by the examined reflecting of at least 10% on pre- and post-intervention measurements

Countries

Brazil

Contacts

Public ContactSuhaila Smaili Santos

Universidade Estadual de Londrina

suhaila@uel.br+55 (43) 9979-2828

Outcome results

None listed

Source: REBEC (via WHO ICTRP)